- Home
- COHN vs NRXS Comparison
COHN vs NRXS Comparison
Compare COHN & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COHN
- NRXS
- Stock Information
- Founded
- COHN 1999
- NRXS 2011
- Country
- COHN United States
- NRXS United States
- Employees
- COHN N/A
- NRXS N/A
- Industry
- COHN Investment Bankers/Brokers/Service
- NRXS
- Sector
- COHN Finance
- NRXS
- Exchange
- COHN Nasdaq
- NRXS Nasdaq
- Market Cap
- COHN 21.6M
- NRXS 25.8M
- IPO Year
- COHN N/A
- NRXS 2023
- Fundamental
- Price
- COHN $13.31
- NRXS $2.45
- Analyst Decision
- COHN
- NRXS Strong Buy
- Analyst Count
- COHN 0
- NRXS 1
- Target Price
- COHN N/A
- NRXS $7.00
- AVG Volume (30 Days)
- COHN 25.4K
- NRXS 1.1M
- Earning Date
- COHN 11-04-2025
- NRXS 11-10-2025
- Dividend Yield
- COHN 7.83%
- NRXS N/A
- EPS Growth
- COHN 6.32
- NRXS N/A
- EPS
- COHN 2.49
- NRXS N/A
- Revenue
- COHN $185,475,000.00
- NRXS $3,362,320.00
- Revenue This Year
- COHN N/A
- NRXS $50.75
- Revenue Next Year
- COHN N/A
- NRXS $130.50
- P/E Ratio
- COHN $4.71
- NRXS N/A
- Revenue Growth
- COHN 107.11
- NRXS 41.93
- 52 Week Low
- COHN $6.10
- NRXS $1.33
- 52 Week High
- COHN $13.56
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- COHN 70.03
- NRXS 35.43
- Support Level
- COHN $9.40
- NRXS $2.40
- Resistance Level
- COHN $10.51
- NRXS $2.66
- Average True Range (ATR)
- COHN 0.76
- NRXS 0.23
- MACD
- COHN 0.26
- NRXS -0.09
- Stochastic Oscillator
- COHN 81.92
- NRXS 6.96
About COHN Cohen & Company Inc.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).